Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visonac photodynamic therapy in severe acne vulgaris
2012-001296-36Phase 2
- Sponsor
- Photocure
- Start
- Mar 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing Visonac PDT with Vehicle control PDT (2 arms). Primary endpoint: Absolute change from baseline in facial inflammatory lesion count.
02
Drugs
methyl aminolevulinate
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2012-001296-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001296-36.